Ma, Tian-Tian
Wong, Ian C. K.
Whittlesea, Cate
Man, Kenneth K. C.
Lau, Wallis
Wang, Zixuan
Brauer, Ruth
MacDonald, Thomas M.
Mackenzie, Isla S.
Wei, Li
Article History
Received: 26 September 2020
Accepted: 4 January 2021
First Online: 3 February 2021
Change Date: 12 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12916-021-02113-2
Ethics approval and consent to participate
: The Health Improvement Network (THIN) database has a single multi-centre ethics approval for all observational studies using THIN data. This study was approved by the THIN Scientific Review Committee (SRC reference: 17THIN100). This study used anonymised data in the THIN database, which does not require the need to obtain informed consent from individual patients.
: All authors have read and approved the submission of the manuscript and give contents for this manuscript to be published.
: Outside the submitted work, Dr. Wong reported receiving a research grant from Research Grant Council of Hong Kong, Pfizer and Bayer to evaluate the use of anticoagulants in Hong Kong. Dr. Mackenzie reported grants from Menarini, IMI, Novartis, Amgen, RTI, George Clinical, Sanofi, NIHR, BHF, Tenovus Scotland, EMA and HDR UK, outside the submitted work.